Conjugate containing an antigenic peptide and its use for preventing bacterial infections caused by Shigella bacteria

PL451249A1Pending Publication Date: 2026-08-24INST IMMUNOLOGII I TERAPII DOSWIADCZAL NEJ PAN
2 Cites 0 Cited by

Patent Information

Application Number
PL2025451249
Authority / Receiving Office
PL · PL
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-02-20
Publication Date
2026-08-24
Patent Text Reader

Abstract

The subject of the application is a conjugate consisting of an antigenic peptide presenting an epitope of the Shigella flexneri 3a OmpC protein of SEQ ID NO: 1, conjugated via the C residue located at the C-terminus of the peptide with a molecule of the carrier protein human serum albumin (HSA), a vaccine composition containing the said conjugate and its use for preventing bacterial infections caused by Shigella bacteria.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • An epitope and its use

    WO2014073998A1

  • Immunogenic conjugate

    WO2016012951A1